Cannabis Freedom Index
← History

Medical 🇨🇭 Switzerland

Switzerland lifts its ban on medical cannabis

An amendment to the Narcotics Act passed on 19 March 2021 took effect. Doctors may prescribe cannabis without asking the federal health office for an exceptional permit each time, and growing and trade for medicine are licensed by Swissmedic.[1][3]

Index score

2829

+1 point

The story · written by opus-5.5,

The Swiss parliament passed an amendment to the Narcotics Act on 19 March 2021. It came into force on 1 August 2022 and lifted the ban on cannabis for medical purposes. Until then cannabis sat among the prohibited narcotics, and each medical use needed an exceptional permit from the Federal Office of Public Health.

A change of list

The mechanics were a move between two official lists. Medical cannabis went from Schedule d, the prohibited narcotics, to Schedule a, the substances subject to all control measures, where methadone and morphine already were. The move covers plants and their parts, preparations such as extracts, resins, oils and tinctures, and THC itself, whenever the purpose is medical. The threshold that makes hemp a narcotic stayed where it was, at 1.0% total THC.

What it means in practice

PointBefore 1 August 2022After
PrescriptionExceptional permit from the federal health officeDoctor prescribes without a permit, and bears sole responsibility
Growing and tradeProhibited narcoticLicensed and controlled by Swissmedic
Commercial exportRestrictedAllowed with a Swissmedic permit
Health insuranceExceptional cases onlyUnchanged

Doctors must report treatment data to the health office during the first years, for a scientific evaluation. The office says the evidence on effectiveness is not yet enough for general reimbursement.

Growing under licence

Swissmedic took on the role of national cannabis agency required by the 1961 Single Convention. A grower needs an operating permit, with protection against theft, and then a separate permit for each crop. That second permit lasts at most twelve months, names one buyer, and requires a written contract under which the buyer takes the entire harvest.

Why the index moved

Only access changed, from 0 to 1. A patient with a prescription now has an ordinary lawful route to cannabis, where before there was only a case-by-case exception. Nothing else moved, because the amendment left everything outside medicine alone: in Swissmedic’s words, cannabis for non-medical purposes remains prohibited and still needs an exceptional permit, which is the basis the pilot sales trials rely on.[1][2]

Score by segment 0 to 10

  1. Possession · 25%4 4
  2. Personal cultivation · 25%1 1
  3. Punishment & enforcement · 20%5 5
  4. Sharing & gifting · 10%3 3
  5. Consumption · 10%2 2
  6. Legal access · 10%0 1+1

The bar shows the score after the change; the tick marks where it stood before. Switzerland's scores have changed again since.

References

  1. Bundesamt für Gesundheit — Gesetzesänderung Cannabisarzneimittelarchived
  2. Swissmedic — Anpassungen in der BetmKV und BetmVV-EDI zu Cannabis für medizinische Zwecke treten auf 1. August 2022 in Kraft (11 July 2022)archived
  3. Wikipedia — Cannabis in Switzerlandarchived

Checked. The date and the event were compared with a source that was read. The score before the change is an editorial estimate.

    ↑↓ to move, ↵ to open.